Moving towards population-based genetic risk prediction for ovarian cancer

BJOG. 2017 May;124(6):855-858. doi: 10.1111/1471-0528.14603.

Authors

B Rahman¹, L Side^{1

2}, S Gibbon³, S F Meisel⁴, L Fraser¹, S Gessler¹, J Wardle, A Lanceley¹

Affiliations

¹ Department of Women's Cancer, EGA Institute for Women's Health, University College London, London, UK.
² North East Thames Regional Genetics Service, London, UK.
³ UCL Anthropology, University College London, London, UK.
⁴ Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, UK.

PMID: 28217902
DOI: 10.1111/1471-0528.14603

No abstract available

MeSH terms

Adult
BRCA1 Protein / analysis
BRCA2 Protein / analysis
Early Detection of Cancer / trends*
Female
Genetic Predisposition to Disease
Genetic Testing / trends*
Humans
Mass Screening / trends*
Middle Aged
Ovarian Neoplasms / diagnosis*
Ovarian Neoplasms / genetics
Risk Factors

Substances

BRCA1 Protein
BRCA1 protein, human
BRCA2 Protein
BRCA2 protein, human